🎧 Listen to episode 4 of VAXXED to hear AIBN's @SethCheetham talk about the scalability of mRNA for clinical use.
As well as leading research at AIBN Seth is the director of the @BASEmRNA - the biggest supplier of mRNA in Australia.
Listen https://t.co/o1IY2Pf7hb
Massive thanks to Professor Wilson and co for dropping by to see what we we’ve been up to at:
💡 The @anffq with Zaw Htoo (Ethan) Aung
🧬 The @BASEmRNA with @SethCheetham
The greatest challenge for #mRNA-LNP therapies is targeting non-liver tissues. To overcome this, we used customisable bispecific antibodies to tether mRNA-LNPs to cell-surface proteins, achieving efficient and selective mRNA delivery in vivo. @BASEmRNA
https://t.co/0nJj8eVsqC
We are excited to share our latest research in bioRxiv, introducing a novel method for targeted mRNA delivery. BASE's Research Team led by @SethCheetham used BsAbs to link mRNA-LNPs to specific cell surface markers. https://t.co/DfvQWGNtHV
We're hiring a senior research assistant to help drive our research ambitious programme in mRNA drug discovery including individualised cancer vaccines. The position join a high-performing team at the @AIBNatUQ@BASEmRNA Please share! Apply 👇
https://t.co/FoeL5HkgQR
🧬Personalised mRNA cancer vaccines are now being used to train the body’s immune system to recognise & eradicate cancer cells.
Despite the potential Aust researchers haven’t had the infrastructure to build these vaccines, leading to a gap in the local drug development pipeline.
You've heard of mRNA from it's use in vaccines, but what actually is it? Could it be used to treat other illnesses?
Watch @SethCheetham, from @BASEmRNA explain how mRNA therapeutics can be tailored to a single individual: making a drug as unique as a fingerprint ☝
We are excited to share that BASE Deputy Director Dr @SethCheetham will be presenting at @Bioprocessingnet Conference 2024 (8-10th Oct). Seth will be sharing about how we accelerate hashtag#mRNA manufacture using synthetic DNA templates.
Connect with the BASE team!
BASE Director Professor Timothy Mercer is at Biomolecular Horizons 2024, Melbourne. Connect with Tim to exchange ideas and research, and how BASE can support your mRNA needs.
#mRNA#partnerships#research
At BASE we design, manufacture, and formulate #mRNA.
We have experience building 400+ mRNAs for a wide range of applications. Book a workshop with our mRNA scientists to design mRNA according to your requirements.
📅 Email [email protected] and book your consultation today!
An info session on TIA's Pipeline Accelerator Scheme will be held next Tuesday (1pm AEST, 10th SEP). A great opportunity to access our mRNA and mRNA-LNP manufacturing capabilities at BASE Facility. https://t.co/RxqFHX1Xco
Contact [email protected] to discuss your mRNA needs!
Therapeutic Innovation Australia's Pipeline Accelerator 2024-25 Round 1 Voucher is now open! This is a great opportunity to have #mRNA and #LNP produced at BASE Facility.
Contact [email protected] to discuss your project needs!
We are hiring for a research fellow to lead research at the new MRFF-funded Australian Centre for Cancer Vaccines. The position will join a passionate team of scientists at one of Australia's leading #mRNA hubs at @AIBNatUQ@BASEmRNA Apply below 👇
https://t.co/WG5wU1iK4I
Last week, BASE Deputy Director @SethCheetham gave a talk at @TEDxUQ 2024 Pulse: Rhythm of Change. He shared about groundbreaking progress in personalised cancer vaccines using #mRNA technology.
Ideas Worth Spreading!💡
Join BASE Deputy Director Dr @SethCheetham
at @TEDxUQ on Saturday, 10th August to hear all about mRNA cancer vaccines!
Tickets & info: https://t.co/Dx9Y5Vlp0m
AIBN's Dr @SethCheetham will be speaking at @TEDxUQ 2024
Dr Cheetham has been pivotal in establishing the @BASEmRNA Facility, Australia’s leading provider of mRNA for research and pilot studies. His research focuses on using mRNA to develop new therapeutics and vaccines. 💉
AIBN's Dr @SethCheetham will be speaking at @TEDxUQ 2024
Dr Cheetham has been pivotal in establishing the @BASEmRNA Facility, Australia’s leading provider of mRNA for research and pilot studies. His research focuses on using mRNA to develop new therapeutics and vaccines. 💉
🧬🔬 More than half the time and cost to manufacture an mRNA vaccine is dedicated quality control - which is currently slow, expensive, and inaccurate.
@Mercerlab and the team at @BASEmRNA are working to change that 🧵